Bram Verstockt, MD, PhD

Dr. Verstockt is an IBD staff physician and professor in the Department of Gastroenterology and Hepatology at University Hospitals Leuven and KU Leuven, Belgium. His clinical and translational research centers on precision medicine in IBD, with a focus on disease heterogeneity, biomarker development, and non-invasive disease monitoring techniques, including intestinal ultrasound and advanced radiologic modalities.

He has played a leading role in international collaborations applying multi-omics, proteomics, and organoid-based platforms to better characterize treatment response and disease behavior in IBD. Dr. Verstockt is also a co-founder of the COLLIBRI proteomics consortium, which advances biomarker discovery and translational research across inflammatory diseases.